Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Fesoterodine fumarate 4 mg prolonged-release tablets

Active Ingredient:
fesoterodine fumarate
Medical Valley Invest AB See contact details
ATC code: 
About Medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
Last updated on emc: 11 Nov 2022
Medical Valley Invest AB
Company image
Bradgardsvagen 28, Hollviken, 236 32, Sweden
+46 40 122 131
Medical Information Direct Line
+46 40 122 131
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)1773 441 688
Stock Availability
+44 (0)1773 441 688